Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Piramal Pharma Solutions (PPS), the global contract manufacturing division of Piramal Pharma Ltd, is set to invest $80 ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, ...

Mumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA ...

Piramal Pharma Solutions is celebrating World Patient Safety Day on 20th September 2024 with a week long celebration aligned with their Patient Centricity initiative. The week of the 16th September ...

Piramal Pharma, chaired by Nandini Piramal, aims to become a global pharma and wellness giant exceeding $2 billion by FY30.

Tata Consumer Products, Indian Railway Catering and Tourism Corporation, Andhra Cements, Zuari Industries, India Glycols, ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, has embarked on its ...